Department of Pharmaceutical Chemistry, University of California, San Francisco (UCSF), San Francisco, California; Skylight Discovery, Inc., Suite 300, Seattle, Washington.
Skylight Discovery, Inc., Suite 300, Seattle, Washington.
Biophys J. 2024 Nov 5;123(21):3678-3687. doi: 10.1016/j.bpj.2024.09.017. Epub 2024 Sep 19.
We present the first demonstration of ligand-induced conformational changes in a biological molecule, a protein, by sum-frequency generation (SFG). Constructs of KRas protein were prepared by selectively deuterating residues of a single amino acid type using isotope-labeled amino acids and cell-free protein synthesis. By attaching labeled protein to a supported bilayer membrane via a His-tag to Ni-NTA-bearing lipids, we ensured that single layers of ordered molecules were formed while preserving the protein's native structure. Exceptionally large SFG amide I signals were produced in both labeled and unlabeled proteins, demonstrating a high degree of orientational order upon attachment to the bilayer. Deuterated protein also produced SFG signals in the CD spectral region, which were not present in the unlabeled protein. The CD signals were measured before and after binding a peptide inhibitor, KRpep-2d, revealing shifts in SFG intensity due to conformational changes at the labeled sites. In particular, peaks associated with CD stretching vibrations for alanine, valine, and glycine changed substantially in amplitude upon inhibitor binding. By inspection of the crystal structure, these three residues are uniquely colocated on the protein surface in and near the nucleotide binding site, which is in allosteric communication with the site of peptide inhibitor binding, suggesting an approach to identify a ligand's binding site. The technique offers a highly sensitive, nonperturbative method of mapping ligand-induced conformational changes and allosteric networks in biological molecules for studies of the relationship between structure and function and mechanisms of action in drug discovery.
我们首次通过和频产生(SFG)展示了生物分子(蛋白质)中配体诱导的构象变化。通过使用同位素标记的氨基酸和无细胞蛋白质合成,选择性地对单个氨基酸类型的残基进行氘取代,构建了 KRas 蛋白质的构建体。通过将标记的蛋白质通过 His 标签连接到带有 Ni-NTA 的脂质上附着到支撑双层膜上,我们确保在保留蛋白质天然结构的同时形成单层有序分子。在标记和未标记的蛋白质中都产生了非常大的 SFG 酰胺 I 信号,这表明在附着到双层膜时具有高度的取向有序性。氘代蛋白质还在 CD 光谱区域产生了 SFG 信号,而未标记的蛋白质中则没有这些信号。在结合肽抑制剂 KRpep-2d 之前和之后测量了 CD 信号,发现由于标记部位的构象变化,SFG 强度发生了变化。特别是,与丙氨酸、缬氨酸和甘氨酸的 CD 伸缩振动相关的峰在抑制剂结合后在幅度上发生了很大变化。通过检查晶体结构,这三个残基在核苷酸结合位点内及其附近独特地位于蛋白质表面上,与肽抑制剂结合位点处于变构通讯中,这表明可以采用这种方法来识别配体的结合位点。该技术提供了一种高度灵敏、非侵入性的方法,可以绘制生物分子中配体诱导的构象变化和变构网络,用于研究结构与功能之间的关系以及药物发现中的作用机制。